Quest Diagnostics Named "Most Admired Company"
News Feb 24, 2015
Quest Diagnostics has announced that it has been named a "Most Admired Company" by Fortune Magazine in the "Health Care: Pharmacy and Other Services" category.
"We are proud that Quest Diagnostics is included on FORTUNE's 2015 World's Most Admired Companies list in our category," said Steve Rusckowski, President and CEO. "The honor is a true team accomplishment, and my thanks and appreciation go to the 45,000 employees who empower better health care every day for the people we serve."
FORTUNE's list of Most Admired Companies is based on surveys of thousands of executives, directors and securities analysts based on nine criteria: innovation; people management; use of corporate assets; social responsibility; quality of management; financial soundness; long-term investment; quality of products and services; and global competitiveness.
The ranking for Quest Diagnostics may be found online at http://fortune.com/worlds-most-admired-companies/quest-diagnostics-100000/.
Most Admired Methodology
The survey employed by FORTUNE to designate its "World's Most Admired Companies" list assesses nine reputation drivers considered to be crucial to a company's global success including financial soundness, long-term investment value, people management, social responsibility, use of assets, quality of management, quality of products/services, innovation and global competitiveness.
These attributes were developed prior to the inception of the Most Admired Companies rankings in the mid-1980s through a series of interviews with executives and industry analysts to determine the qualities that make a company worthy of admiration.
Raters are asked to evaluate each eligible company on attributes by assigning a score from zero ('Poor') to ten ('Excellent'). For the purposes of the industry rankings, a company's overall score is determined through a simple average of the individual attribute scores. Companies who rank in the top half of their industry are defined as "most admired" within their industry.
In recent years, numerous studies have shown that people who don't get enough sleep are at greater risk of stroke and heart attack. A study found that people who sleep fewer than 7 hours per night have lower blood levels of three physiological regulators, or microRNAs, which influence gene expression and play a key role in maintaining vascular health.